Efficacy of long term cyclic administration of the poorly absorbed Rifaximin in symptomatic, uncomplicted colonic diverticular disease

World Journal of Gastroenterology

Volumn 13, Issue 2, 2007, Pages 264-269

  Colecchia, Antonio ^a   Vestito, Amanda ^a   Pasqui, Francesca ^a   Mazzella, Giuseppe ^a   Roda, Enrico ^a   Pistola, Francesca ^b   Brandimarte, Giovanni ^c   Festi, Davide ^a,d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c Cristo Re Hospital   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Abdominal symptoms; Antibiotics; Dietary fiber; Diverticulitis

Indexed keywords

RIFAXIMIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLON DIVERTICULOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY FIBER; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

EID: 33846935785     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i2.264     Document Type: Article

References (28)

1. Stollman N, Raskin JB. Diverticular disease of the colon. Lancet 2004; 363: 631-639
2. Delvaux M. Diverticular disease of the colon in Europe: epidemiology, impact on citizen health and prevention. Aliment Pharmacol Ther 2003; 18 Suppl 3: 71-74
3. Parks TG. Natural history of diverticular disease of the colon. Clin Gastroenterol 1975; 4: 53-69
4. Kang JY, Melville D, Maxwell JD. Epidemiology and management of diverticular disease of the colon. Drugs Aging 2004; 21: 211-228
5. Farmakis N, Tudor RG, Keighley MR. The 5-year natural history of complicated diverticular disease. Br J Surg 1994; 81: 733-735
6. Bolster LT, Papagrigoriadis S. Diverticular disease has an impact on quality of life - results of a preliminary study. Colorectal Dis 2003; 5: 320-323
7. Kohler L, Sauerland S, Neugebauer E. Diagnosis and treatment of diverticular disease: results of a consensus development conference. The Scientific Committee of the European Association for Endoscopic Surgery. Surg Endosc 1999; 13: 430-436
8. Stollman NH, Raskin JB. Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1999; 94: 3110-3121
9. Mizuki A, Nagata H, Tatemichi M, Kaneda S, Tsukada N, Ishii H, Hibi T. The out-patient management of patients with acute mild-to-moderate colonic diverticulitis. Aliment Pharmacol Ther 2005; 21: 889-897
10. Simpson J, Spiller R. Colonic diverticular disease. Clin Evid 2004;: 599-609
11. Gillis JC, Brogden RN. Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs 1995; 49: 467-484
12. Papi C, Ciaco A, Koch M, Capurso L. Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group. Ital J Gastroenterol 1992; 24: 452-456
13. Ventrucci M, Ferrieri A, Bergami R, Roda E. Evaluation of the effect of rifaximin in colon diverticular disease by means of lactulose hydrogen breath test. Curr Med Res Opin 1994; 13: 202-206
14. Papi C, Ciaco A, Koch M, Capurso L. Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 1995; 9: 33-39
15. Latella G, Pimpo MT, Sottili S, Zippi M, Viscido, A, Chiaramonte M, Frieri G. Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 2003; 18: 55-62
16. Casagrande JT, Pike MC. An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics 1978; 34: 483-486
17. Armitage P, Berry G. Statistical methods in medical research. Black-Well Scientific Publication Limited, Oxford, 1994
18. Aldoori WH, Giovannucci EL, Rimm EB, Wing AL, Trichopoulos DV, Willett WC. A prospective study of diet and the risk of symptomatic diverticular disease in men. Am J Clin Nutr 1994; 60: 757-764
19. Colecchia A, Sandri L, Capodicasa S, Vestito A, Mazzella G, Staniscia T, Roda E, Festi D. Diverticular disease of the colon: new perspectives in symptom development and treatment. World J Gastroenterol 2003; 9: 1385-1389
20. Bassotti G, Battaglia E, De Roberto G, Morelli A, Tonini M, Villanacci V. Alterations in colonic motility and relationship to pain in colonic diverticulosis. Clin Gastroenterol Hepatol 2005; 3: 248-253
21. Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon. World J Gastroenterol 2005; 11: 2773-2776
22. Simpson JK, Metcalfe DD. Mastocytosis and disorders of mast cell proliferation. Clin Rev Allergy Immunol 2002; 22: 175-188
23. Petruzziello L, Iacopini F, Bulajic M, Shah S, Costamagna G. Review article: uncomplicated diverticular disease of the colon. Aliment Pharmacol Ther 2006; 23: 1379-11391
24. Lupton JR, Turner ND. Potential protective mechanisms of wheat bran fiber. Am J Med 1999; 106: 24S-27S
25. Brodribb AJ. Treatment of symptomatic diverticular disease with a high-fibre diet. Lancet 1977; 1: 664-666
26. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome? Gut 2002; 51 Suppl. 1: i41-i44
27. Papi C, Koch M, Capurso, L. Management of diverticular disease is there room for rifaximin? Chemotherapy 2005, 51 Suppl 1: 110-4
28. Kurpad AV, Shetty PS. Effects of antimicrobial therapy on faecal bulking. Gut 1986; 27: 55-58